Preface; Acknowledgments; Part One: Protecting Human Subjects in Clinical Research: A General Perspective; 1. Miller FG. Situating research ethics: revisiting Beecher and Jonas; 2. Miller FG, Wertheimer A. Facing up to paternalism in research ethics. Hastings Center Report 2007;37(3):24-34.; 3. Miller FG, Joffe S. Limits to research risks. Journal of Medical Ethics 2009;35:445-449.; Part Two: Study Design; 4. Miller FG, Rosenstein DL. Psychiatric symptom-provoking studies: an ethical appraisal. Biological Psychiatry. 1997;42:403-9.; 5. Miller FG, Grady C. The ethical challenge of infection-inducing challenge experiments. Clinical Infectious Diseases. 2001;33:1028-33.; 6. Miller FG. Placebo-controlled trials in psychiatric research: an ethical perspective. Biological Psychiatry. 2000;47:707-16.; 7. Miller FG, Brody H. What makes placebo-controlled trials unethical? The American Journal of Bioethics. 2002;2(2):3-9.; 8. Miller FG, Emanuel EJ, Rosenstein DL, Straus SE. Ethical issues concerning research on complementary and alternative medicine. JAMA 2004;291:599-604.; 9. Miller FG. Sham surgery: an ethical analysis. American Journal of Bioethics 2003;3(4):41-8;; 10. Miller FG, Joffe S. Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option? Clinical Trials 2008;5:617-23.; 11. Miller FG, Wendler D, Swartzman L. Deception in research on the placebo effect. PLoS Medicine 2005;2(9):e262.; 12. Miller FG, Gluck JP, Wendler D. Debriefing and accountability in deceptive research. Kennedy Institute of Ethics Journal 2008;18:235-51.; Part Three: Therapeutic Orientation and Equipoise; 13. Miller FG, Rosenstein DL, DeRenzo EG. Professional integrity in clinical research. Journal of the American Medical Association. 1998;280:1449-54.; 14. Miller FG, Rosenstein DL. The therapeutic orientation to clinical trials. New England Journal of Medicine. 2003;348:1383-86.; 15. Miller FG, Brody H. A critique of clinical equipoise: Therapeutic misconception in the ethics of clinical trials. Hastings Center Report. 2003;33(3):19-28.; 16. Miller FG, Brody H. Clinical equipoise and the incoherence of research ethics. Journal; of Medicine and Philosophy 2007;32:151-65.; 17. Miller FG, Joffe S. Equipoise and the randomized clinical trial dilemma. New England Journal of Medicine 2011;364:476-80.; Part Four: Consent; 18. Miller FG, Joffe S. Evaluating the therapeutic misconception. Kennedy Institute of Ethics Journal 2006;16:353-66.; 19. Miller FG, Wendler D. Is it ethical to keep interim findings of randomized controlled trials confidential? Journal of Medical Ethics 2008;34:198-201.; 20. Miller FG. Research on medical records without informed consent, Journal of Law, Medicine & Ethics 2008;36:560-66.; 21. Miller FG, Pearson SD. Coverage with evidence development: ethical issues and policy implications. Medical Care 2008;46:746-57.; 22. Miller FG, Wertheimer A. The fair transaction model of informed consent: an alternative to autonomous authorization, Kennedy Institute of Ethics Journal 2011;21:201-18.